Lux Capital
Emerging Technology VC
Lux Capital Management is a research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth...Founded in 2000
Employees: 10
Homepage: http://www.luxcapital.com/
HQ
10017 295 Madison Avenue24th Floor
New York
USA NY
Phone: 646-475-4385
Lux Capital at CrunchBase
Peter Hebert Co-Founder and Managing Partner
Robert Paull Co-Founder and Managing Partner
Jeffrey B. Kindler Venture Partner
Jim Woolsey Partner
Past
March, 2013
Lux Capital invested $5.6M in Matterport as a Series A round
February, 2013
Lux Capital invested $11.5M in Kala Pharmaceuticals as a Series A round
January, 2013
Lux Capital invested $11M in Kyruus as a Series B round
November, 2012
Lux Capital invested $13M in Visterra as a Series A round
October, 2012
Lux Capital invested $30M in Genocea Biosciences as a Series C round
August, 2012
Lux Capital invested $12M in Kymeta as unattributed round
July, 2012
Lux Capital invested $30M in Siluria Technologies as a Series C round
June, 2012
Lux Capital invested $6.2M in Shapeways as a Series B round
March, 2012
Lux Capital invested $6.2M in Kala Pharmaceuticals as unattributed round
February, 2012
Lux Capital invested $21.7M in Luxtera as a Series C round
December, 2011
Lux Capital invested $15M in Cerulean Pharma as a Series D round
September, 2011
Lux Capital invested $20M in Siluria Technologies as a Series B round
June, 2011
Lux Capital invested $25M in Transphorm as a Series D round
February, 2011
Lux Capital invested $20M in Transphorm as a Series C round
January, 2011
Lux Capital invested $35M in Genocea Biosciences as a Series B round
November, 2010
Lux Capital invested $24M in Cerulean Pharma as a Series C round
October, 2010
Lux Capital invested $13.3M in Siluria Technologies as unattributed round
August, 2010
Lux Capital invested $4M in Crystal IS as a Series B round
Lux Capital invested $6M in Visterra as a Series A round
November, 2009
Lux Capital invested $14.5M in Cambrios Technologies as a Series D round
July, 2009
Lux Capital invested $10M in Cerulean Pharma as a Series B round
May, 2009
Lux Capital invested $3.3M in Parasol Therapeutics as a Series A round
April, 2008
Lux Capital invested $20M in EverSpin Technologies as a Series A round
January, 2008
Lux Capital invested $8.1M in Cerulean Pharma as a Series B round
November, 2007
Lux Capital invested $8M in Silicon Clocks as unattributed round
May, 2007
Lux Capital invested $12.1M in Cerulean Pharma as a Series A round
August, 2006
Lux Capital invested $10.6M in Crystal IS as a Series B round
November, 2005
Lux Capital invested $41.5M in nanosys as a Series D round
February, 2005
Lux Capital invested $12M in Cambrios Technologies as a Series B round
2000
Lux Capital was founded in 2000